The Office of the U.S. Trade Representative (“USTR”) has announced that it is extending certain expiring China 301 tariff exclusions and is designating certain additional such exclusions.  The USTR is taking these actions with respect to certain medical-care products to reflect the rising spread and ongoing efforts to combat COVID-19.  (Notice accessible at: https://ustr.gov/sites/default/files/enforcement/301Investigations/COVID_Extensions_December_2020.pdf). In […]